GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Scivision Biotech Inc (TPE:1786) » Definitions » Total Long-Term Liabilities

Scivision Biotech (TPE:1786) Total Long-Term Liabilities : NT$117.7 Mil (As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is Scivision Biotech Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Scivision Biotech's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was NT$117.7 Mil.

Scivision Biotech Total Long-Term Liabilities Historical Data

The historical data trend for Scivision Biotech's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scivision Biotech Total Long-Term Liabilities Chart

Scivision Biotech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 364.94 386.42 459.22 388.67 120.36

Scivision Biotech Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 364.81 270.64 198.20 120.36 117.68

Scivision Biotech Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Scivision Biotech Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Scivision Biotech's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Scivision Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Scivision Biotech Inc (TPE:1786) » Definitions » Total Long-Term Liabilities
Comparable Companies
ROCO:4126 ROCO:4107 ROCO:1565 ROCO:6612 TPE:4737 TPE:1783 ROCO:5312 TPE:1752 ROCO:6499 ROCO:6527 ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD TSE:4543 OCSE:COLO B XPAR:DIM XSWX:STMN
Traded in Other Exchanges
N/A
Address
No. 1, South 1st Road, KEPZ, Kaohsiung, TWN, 806
Website
https://www.scivisionbiotech.com
Scivision Biotech Inc is engaged in the manufacturing and distribution of hyaluronic acid medical supplies in Taiwan. It offers medical devices, including absorbable adhesion barriers, dermal implants, synovial fluid supplements, and intravesical instillation.

Scivision Biotech Headlines

No Headlines